1 |
Yoshikawa S, Taniguchi K, Sawamura H, Ikeda Y, Tsuji A, Matsuda S. Advantageous tactics with certain probiotics for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantation. World J Hematol 2023; 10(2): 15-24 [DOI: 10.5315/wjh.v10.i2.15] [Reference Citation Analysis]
|
2 |
Ikeda Y, Taniguchi K, Yoshikawa S, Sawamura H, Tsuji A, Matsuda S. A budding concept with certain microbiota, anti-proliferative family proteins, and engram theory for the innovative treatment of colon cancer. Exploration of Medicine 2022;2:468-478. [DOI: 10.37349/emed.2022.00108] [Reference Citation Analysis]
|
3 |
Zhang N, Guan C, Liu Z, Li C, Yang C, Xu L, Niu M, Zhao L, Zhou B, Che L, Wang Y, Xu Y. Calycosin attenuates renal ischemia/reperfusion injury by suppressing NF-κB mediated inflammation via PPARγ/EGR1 pathway. Front Pharmacol 2022;13:970616. [DOI: 10.3389/fphar.2022.970616] [Reference Citation Analysis]
|
4 |
Sawamura H, Taniguchi K, Ikeda Y, Tsuji A, Kitagishi Y, Matsuda S. Gut microbiota could modulate the effects of neuro-immune responses and memory traces via the gut-brain-immune axis in schizophrenia. Explor Neuroprot Ther 2022. [DOI: 10.37349/ent.2022.00019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|